Cartesian Therapeutics (RNAC)'s 30-day implied volatility (IV30) was 84.7% at the close on October 23, 2026, up from 81.3% the day before, against a 52-week range of 50.1% to 116.6%. Its 20-day historical volatility was 77.6%.
Data as of October 23, 2026.